Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Rana McKay, MD, University of California, San Diego, CA, discusses the ways in which we can optimize first-line systemic therapy selection in the treatment of renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.